We have established a full-cycle R&D function, from the discovery of medical needs through product development to commercialization. We review and discuss feedback from KOLs, physicians and academic institutions to identify potential research and development opportunities. Through those communications, we develop or adjust our products, which ensures market acceptance of, and demand for, our products later on.
Our R&D team has a full suite of R&D capabilities related to structural heart disease medical device, including biological material, suturing techniques, structure design and processing techniques. In addition, we have set up a biological laboratory aimed at developing innovative anti-calcification animal-derived valve materials. In addition, we have established a simulation laboratory integrating both computer-aided engineering (CAE) analysis and valve testing, which enables us to conduct in vitro experiments to dissect the mechanisms of our product candidates during the process development stage. Going forward, we will continuously expand our product pipeline through our research and development efforts to strengthen our competitive advantages.
Through over ten years of R&D experience in the class III medical device field, we have accumulated abundant experience in conducting every critical stage of clinical trials including planning, designing, execution, data management and data analysis. We also engage reputable, experienced CROs to support our day-to-day clinical development execution.